Hims & Hers Health, Inc.'s (HIMS) investors are encountering some short-term losses from the stock of late. Shares of the San Francisco, CA-based health and wellness platform have plunged 32.1% in the past three months, underperforming the industry's 11.4% gain. In the same time frame, the stock underperformed the sector and S&P 500's 4.7% and 2.7% growth, respectively. Two major developments from HIMS in recent months include the announcement of its second-quarter 2024 results (in August) and the addition ...